Mechanical Circulatory Support, by Drs. Robert L. Kormos and Leslie W. Miller, provides the clinically relevant information you need to effectively use this therapy to treat and manage end-stage cardiovascular disease. In this Companion to Braunwald's Heart Disease, the world's most prominent experts in mechanical circulatory support (MCS) cover basic science, device construction, clinical applications, socioeconomic implications, future directions, and more. Stay on top of hot topics - including innovative devices like continuous flow pumps, next-generation centrifugal pumps, and total artificial hearts; MCS for pediatric and congenital heart disease; cellular, molecular, genomic, and functional changes that occur in the failing heart in response to MCS; and Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS) as a tool to track and advance clinical practice. You'll also have access the fully searchable text online at www.expertconsult.com.
Access the fully searchable text online at www.expertconsult.com.
Tap into discussions of hot topics in mechanical circulatory support (MCS), including current types of devices and clinical settings for MCS; MCS for pediatric and congenital heart disease; myocardial recovery, regenerative therapy, bleeding and thrombosis with MCS; cellular, molecular, genomic, and functional changes that occur in the failing heart in response to MCS; and Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS) as a tool to track and advance clinical practice.
Get a complete picture of the role of mechanical circulatory support in treatment through coverage of device construction, clinical applications, socioeconomic implications, and future directions.
Master the pathophysiology and rationale of treatment with discussions of basic science in addition to clinically-relevant information and current clinical practice guidelines.
Apply the expertise of the world's most prominent leaders in mechanical circulatory support.
11. Surgical Methods for Mechanical Circulatory Support
12. Intraoperative Management Issues in Mechanical Circulatory Support
13. Adverse Events and Complications of Mechanical Circulatory Support
14. Pre-Discharge and Outpatient Management
15. Psychosocial and Quality of Life Issues in Mechanical Circulatory Support
16. Mechanical Circulatory Support in Pediatrics
17. Myocardial Recovery with Use of Mechanical Circulatory Support
18. Regenerative Therapy as an Adjunct to Recovery with MCS
19. Biologic Responses to the Interface Between Device and Circulation: Bleeding and Thrombosis with MCS
20. Cellular, Molecular, Genomic, and Functional Changes that Occur in the Failing Heart in Response to Mechanical Circulatory Support
21. Results of Clinical Trials to Date
22. Design Challenges for Clinical Trials in Mechanical Circulatory Support
23. Regulatory Framework for Mechanical Circulatory Support
24. Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS) as a Tool to Track and Advance Clinical Practice
25. Reimbursement and Funding Framework for Mechanical Circulatory Support
26. The Future of Mechanical Circulatory Support
By Robert L. Kormos, MD, FRCS(C), FACS, FAHA, Professor of Surgery
Co-Director, Heart Transplantation
Director, Artificial Heart Program
Heart and Vascular Institute
University of Pittsburgh Medical Center
and Leslie W. Miller, MD, Edward C. Wright Professor of Cardiovascular Medicine
Chair, Department of Cardiovascular Sciences
CEO of Cardiovascular Clinical Research
University of South Florida Health